3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Gastrointestinal
1
Breast
1
Conditions
Breast Cancer Female
1
Interventions
Letrozole
23
Docetaxel
17
Cyclophosphamide
13
Zoledronic Acid
12
Trastuzumab
12
Anastrozole
12
exemestane
11
Tamoxifen
11
Paclitaxel
11
Capecitabine
10
Fulvestrant
8
Epirubicin
8
pegfilgrastim
7
Saline Solution
7
Bupivacaine
7
pertuzumab
6
liposomal doxorubicin
6
abemaciclib
6
Sodium Chloride
6
Filgrastim
6
Carboplatin
6
pegylated granulocyte colony-stimulating factor
5
palbociclib
5
Ropivacaine
5
Dexmedetomidine
5
Bevacizumab
5
ribociclib
4
eribulin
4
Vinorelbine
4
Tranexamic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Ketorolac Tromethamine
×
Breast
×
Clear all
NCT03007381
2017-08-16
KANGAROO
Nova Scotia Health Authority
Phase 4
Withdrawn